Loss Ratio (Quarterly)

Loss Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The loss ratio is calculated by taking the incurred underwriting losses and then dividing them by earned premium. Calculated as: Underwriting Losses Total / Net Premiums Earned

Amphastar Pharmaceuticals, Inc. (AMPH) Loss Ratio data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$171.17M
Net Income	$6.42M
Cost of Goods Sold	$100.85M
Gross Profit	$70.32M
Operating Expenses	$157.54M
Operating Income	$13.63M
Non-Operating Income/Expense	$-3.58M
Pre-Tax Income	$10.05M
Normalized Pre-Tax Income	$10.05M
Income after Taxes	$6.42M
Income from Continuous Operations	$6.42M
Consolidated Net Income/Loss	$6.42M
Normalized Income after Taxes	$6.42M
EBIT	$13.63M
EBITDA	$28.74M
Weighted-Average Shares Outstanding (Basic)	45.32M
Weighted-Average Shares Outstanding (Diluted)	46.46M
Earnings per Share (EPS) (Basic)	$0.14
Earnings per Share (EPS) (Diluted)	$0.14
Balance Sheet Financials
Current Assets	$633.68M
Property, Plant, and Equipment	$307.23M
Long-Term Assets	$1.01B
Total Assets	$1.65B
Current Liabilities	$164.48M
Long-Term Debt	$609.80M
Long-Term Liabilities	$710.29M
Total Liabilities	$874.77M
Common Equity	$773.39M
Tangible Shareholders Equity	$213.77M
Shareholders Equity	$773.39M
Common Shares Outstanding	44.64M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$47.84M
Cash Flow from Investing Activities	$-16.73M
Cash Flow from Financial Activities	$-30.21M
Beginning Cash	$170.41M
End Cash	$171.17M
Increase/Decrease in Cash	$0.76M
Stock-Based Compensation	$9.27M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.85
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.44
Debt to Equity Ratio	0.79
Gross Margin	41.08%
Operating Margin	7.96%
EBIT Margin	7.96%
EBITDA Margin	--
Pre-Tax Profit Margin	5.87%
Profit Margin	3.75%
Free Cash Flow	$38.33M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.10
Inventory Turnover	0.59
Receiveable Turnover	1.09
Days Sales in Receivables	82.79
Return on Equity	0.83%
Return on Tangible Equity	3.00%
Return on Assets	0.39%
Return on Investments	0.46%
Book Value Per Share	$17.33
Free Cash Flow per Share	$0.83
Operating Cash Flow per Share	$1.03

Data from Zacks Investment Research, Inc.